Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1 and 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01757756
What this trial is testing

Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 12
Not applicableStudy completedNCT03489031
What this trial is testing

Basal Insulin And Compensation Glycemic In Diabetic Patients In Basal Bolus Outpatient.

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Associazione Medici Endocrinologi 1,036
Testing effectiveness (Phase 2)UnknownNCT01557634
What this trial is testing

Closing the Loop in Young Children With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Daniela Elleri 12
Not applicableStudy completedNCT04253431
What this trial is testing

The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
HTL-Strefa S.A. 60
Testing effectiveness (Phase 2)Study completedNCT02713841
What this trial is testing

Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Dance Biopharm Inc. 12
Testing effectiveness (Phase 2)Study completedNCT04450407
What this trial is testing

LY3209590 in Participants With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Eli Lilly and Company 266
Not applicableStudy completedNCT00700765
What this trial is testing

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,531
Early research (Phase 1)Looking for participantsNCT05610865
What this trial is testing

Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot UlcerDiabetes MellitusDiabetic Foot+8 more
University of the Punjab 28
Large-scale testing (Phase 3)Ended earlyNCT00226330
What this trial is testing

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 1,100
Early research (Phase 1)Ended earlyNCT01492465
What this trial is testing

Single Ascending Dose Trial in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Amgen 47
Not applicableStudy completedNCT03785379
What this trial is testing

A Trial Evaluating the Effects of a One-year Lifestyle Intervention in Obese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
University of Padova 23
Not applicableUnknownNCT05660941
What this trial is testing

Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)

Who this might be right for
Diabetes Mellitus, Type 1
Manchester University NHS Foundation Trust 26
Large-scale testing (Phase 3)Study completedNCT04974528
What this trial is testing

Afrezza® INHALE-1 Study in Pediatrics

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Mannkind Corporation 319
Large-scale testing (Phase 3)Study completedNCT00437554
What this trial is testing

Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)

Who this might be right for
Diabetes Mellitus, Type 2
Handok Inc. 188
Very early researchStudy completedNCT00935051
What this trial is testing

Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
University Hospital, Grenoble 59
Early research (Phase 1)Study completedNCT06423872
What this trial is testing

A SAD Study of ZT002 Injection in Healthy Participants

Who this might be right for
Type 2 Diabetes Mellitus
Beijing QL Biopharmaceutical Co.,Ltd 28
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Testing effectiveness (Phase 2)Study completedNCT00441844
What this trial is testing

Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation

Who this might be right for
Type 1 Diabetes
University of California, Davis 50
Early research (Phase 1)Study completedNCT01129258
What this trial is testing

Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 110
Testing effectiveness (Phase 2)Ended earlyNCT04628481
What this trial is testing

Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Who this might be right for
Recent Onset type1 Diabetes
Dompé Farmaceutici S.p.A 289
Next Page